This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Columbia University. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: The Innovations of Boglarka Racz
Introduction
Boglarka Racz is a notable inventor based in Brooklyn, NY. He has made significant contributions to the field of medical research, particularly in the treatment of non-alcoholic fatty liver disease and gout. His innovative approach has led to the development of a unique pharmaceutical composition that targets specific health issues.
Latest Patents
Boglarka Racz holds 1 patent for his invention titled "RBP4 antagonists for treatment and prevention of non-alcoholic fatty liver disease and gout." This patent outlines a method for treating non-alcoholic fatty liver disease (NAFLD) by administering a pharmaceutical composition that includes a non-retinoid retinol-binding protein 4 (RBP4) antagonist. Additionally, the invention provides a method for treating gout using a similar pharmaceutical composition.
Career Highlights
Boglarka Racz is affiliated with Columbia University, where he conducts research and develops innovative solutions in the medical field. His work has garnered attention for its potential impact on treating prevalent health conditions.
Collaborations
Boglarka collaborates with esteemed colleagues such as Konstantin Petrukhin and Andras Varadi. Their combined expertise enhances the research and development efforts at Columbia University.
Conclusion
Boglarka Racz's contributions to medical research through his innovative patents demonstrate his commitment to improving health outcomes. His work in developing treatments for non-alcoholic fatty liver disease and gout showcases the importance of innovation in addressing critical health challenges.